Reversible parkinsonism and ataxia associated with high-dose octreotide.
Espay
Alberto J
AJ
Department of Neurology, University of Cincinnati, 231 Albert Sabin Way, MSB 4503, Cincinnati, OH 45267-0525, USA. alberto.espay@uc.edu
D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use / Q000633:toxicity*; D001259:Ataxia / Q000139:chemically induced*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy; D015282:Octreotide / Q000627:therapeutic use / Q000633:toxicity*; D020734:Parkinsonian Disorders / Q000139:chemically induced*
D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide